-
Studies at Parkinson’s Congress Cover Off-periods and Work, Inbrija’s Ability to Keep Dyskinesia at Bay
Study data presented by Acorda at the International Congress of Parkinson’s Disease and Movement Disorders support the benefits of its Inbrija (levodopa). Read more here.
What do you think of this news?
Log in to reply.